We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-28.95%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$79.3M
AUM Growth
-$67.7M
Cap. Flow
-$24.1M
Cap. Flow %
-30.41%
Top 10 Hldgs %
54.45%
Holding
159
New
32
Increased
24
Reduced
41
Closed
43

Sector Composition

Rank Sector Weight
1 Healthcare 36.68%
2 Technology 5.89%
3 Consumer Discretionary 4.32%
4 Industrials 3.44%
5 Energy 1.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAN
26
PUT
Canaan Creative
CAN
$178M
$730K 0.92%
2,225
-2,928
-57% -$10.7K
LEXXW
27
DELISTED
Lexaria Bioscience Warrant
LEXXW
$699K 0.88%
285,360
-58,174
-17% -$44.7K
VINC
28
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$698K 0.88%
25,278
+250
+1% +$7.19K
WLDS icon
29
Wearable Devices
WLDS
$8.39M
$654K 0.83%
+1,033
New +$1.24M
GLBS icon
30
Globus Maritime Ltd
GLBS
$60.9M
$638K 0.8%
506,659
-29,110
-5% -$46.8K
ADTX
31
DELISTED
ADITXT INC
ADTX
0
AWH
32
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$584K 0.74%
+104,652
New +$1.13M
OG
33
DELISTED
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
$578K 0.73%
1,713,689
+392,939
+30% +$223K
GWAV icon
34
Greenwave Technology Solutions
GWAV
$2.06M
$544K 0.69%
+19
New +$987K
LUCYW icon
35
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
$60.6K
$530K 0.67%
+381,640
New +$252K
BCTX
36
Briacell Therapeutics
BCTX
$30.2M
$528K 0.67%
627
+243
+63% +$244K
WLDSW icon
37
Wearable Devices Ltd Warrant
WLDSW
$135K
$515K 0.65%
+3,423
New +$610K
KUST
38
Kustom Entertainment Inc
KUST
$639K
$509K 0.64%
+2
New +$821K
IONM
39
DELISTED
Assure Holdings Corp. Common Stock
IONM
$496K 0.63%
+2,153
New +$889K
AGMH icon
40
AGM Group Holdings
AGMH
$1.82M
$481K 0.61%
5,980
-8,721
-59% -$856K
GMBLZ
41
DELISTED
Esports Entertainment Group Inc. Warrant
GMBLZ
$458K 0.58%
3,723,748
+108,035
+3% +$13.3K
PMCB icon
42
PUT
PharmaCyte Biotech
PMCB
$6.33M
$414K 0.52%
1,723
IVDA icon
43
Iveda Solutions
IVDA
$2.6M
$413K 0.52%
+79,430
New +$701K
ATOS icon
44
PUT
Atossa Therapeutics
ATOS
$24.1M
$391K 0.49%
313
-431
-58% -$6.26K
XWEL icon
45
PUT
XWELL
XWEL
$8.87M
$377K 0.48%
246
BRSHW
46
DELISTED
Bruush Oral Care Inc. Warrant
BRSHW
$372K 0.47%
+365,752
New +$168K
SBEV.WS
47
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$370K 0.47%
270,163
-33,509
-11% -$22.5K
CRIS icon
48
Curis
CRIS
$9.41M
$350K 0.44%
1,250
+25
+2% +$10.1K
ATOS icon
49
Atossa Therapeutics
ATOS
$24.1M
$343K 0.43%
27,460
-7,527
-22% -$109K
NCRA icon
50
Nocera
NCRA
$2.23M
$318K 0.4%
+7,581
New +$465K

Similar funds

Sabby Management's Q3 2022 Portfolio in Review

As of Q3 2022, Sabby Management held 159 positions worth $79.3M, down 46% from $147M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Sabby Management withdrew a net $24.1M in Q3 2022, closing 43 positions and reducing 41 holdings. Its most notable exit was Gevo, an estimated $15.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Sabby Management opened a new position in Bright Green Corporation Common Stock worth $5.14M.

  • Sabby Management's largest Q3 2022 buy was Bright Green Corporation Common Stock: 4,761,905 shares worth $5.14M.
  • Sabby Management added most to Dogness International Corp in Q3 2022, an estimated $513K increase.
  • Sabby Management's biggest Q3 2022 reduction was BioVie, cutting an estimated $1.26M.
  • Sabby Management fully exited Gevo in Q3 2022, selling an estimated $15.3M.
  • Sabby Management's ten largest holdings make up 54% of its $79.3M portfolio in Q3 2022.
  • Sabby Management opened 32 new positions and closed 43 in Q3 2022.
  • Sabby Management's portfolio value fell 46% quarter-over-quarter to $79.3M.

Based on Sabby Management's 13F filing for Q3 2022, filed 14 Nov 2022.